{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:26:04Z","timestamp":1793129164453,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH NIGMS","doi-asserted-by":"publisher","award":["R35GM128675"],"award-info":[{"award-number":["R35GM128675"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbamcr.2025.119986","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T02:21:39Z","timestamp":1746757299000},"page":"119986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inhibition of NAMPT as a therapeutic strategy to suppress tumor growth in lymphangioleiomyomatosis"],"prefix":"10.1016","volume":"1872","author":[{"given":"Shahrzad S.","family":"Fard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alek S.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Faltas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie S.","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina K.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbamcr.2025.119986_bb0005","doi-asserted-by":"crossref","first-page":"C320","DOI":"10.1152\/ajpcell.00202.2022","article-title":"Lymphangioleiomyomatosis: a metastatic lung disease","volume":"324","author":"Kundu","year":"2023","journal-title":"Am. J. Phys. Cell Physiol."},{"issue":"12","key":"10.1016\/j.bbamcr.2025.119986_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.502","article-title":"Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb\/mTOR pathway","volume":"5","author":"Makovski","year":"2014","journal-title":"Cell Death Dis."},{"issue":"17","key":"10.1016\/j.bbamcr.2025.119986_bb0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bbamcr.2025.119986_bb0020","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"13","key":"10.1016\/j.bbamcr.2025.119986_bb0025","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","article-title":"Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism","volume":"26","author":"Wan","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbamcr.2025.119986_bb0030","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1535-7163.MCT-08-0668","article-title":"Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K\/mTOR inhibition","volume":"8","author":"Breuleux","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.119986_bb0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.119986_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","article-title":"NAD+ homeostasis in health and disease","volume":"2","author":"Katsyuba","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.bbamcr.2025.119986_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106189","article-title":"NAMPT: a critical driver and therapeutic target for cancer","volume":"145","author":"Gasparrini","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbamcr.2025.119986_bb0050","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/ijms25042092","article-title":"Inhibitors of NAD+ production in Cancer treatment: state of the art and perspectives","volume":"25","author":"Ghanem","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2025.119986_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.970553","article-title":"Review of various NAMPT inhibitors for the treatment of cancer","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbamcr.2025.119986_bb0060","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy","volume":"8","author":"Hardie","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbamcr.2025.119986_bb0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2025.119986_bb0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2021.04.006","article-title":"AMPK signaling and its targeting in cancer progression and treatment","volume":"85","author":"Hsu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.119986_bb0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/fon.09.174","article-title":"AMPK as a metabolic tumor suppressor: control of metabolism and cell growth","volume":"6","author":"Luo","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbamcr.2025.119986_bb0080","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3389\/fphar.2020.00656","article-title":"Recent advances in NAMPT inhibitors: a novel Immunotherapic strategy","volume":"11","author":"Galli","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"21","key":"10.1016\/j.bbamcr.2025.119986_bb0085","first-page":"7436","article-title":"FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis","volume":"63","author":"Hasmann","year":"2003","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.bbamcr.2025.119986_bb0090","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1158\/1078-0432.CCR-14-0624","article-title":"On-target effect of FK866, a nicotinamide phosphoribosyl transferase inhibitor, by apoptosis-mediated death in chronic lymphocytic leukemia cells","volume":"20","author":"Gehrke","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbamcr.2025.119986_bb0095","first-page":"1251","article-title":"Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil","volume":"26","author":"Bi","year":"2011","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.bbamcr.2025.119986_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050775","article-title":"The NAMPT inhibitor FK866 in combination with cisplatin reduces cholangiocarcinoma cells growth","volume":"12","author":"Pant","year":"2023","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.bbamcr.2025.119986_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225597","article-title":"The NAMPT inhibitor FK866 increases metformin sensitivity in pancreatic Cancer cells","volume":"14","author":"Parisotto","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bbamcr.2025.119986_bb0110","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbrc.2015.01.111","article-title":"FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells","volume":"458","author":"Schuster","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bbamcr.2025.119986_bb0115","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2174\/1871520623666221025145320","article-title":"Overexpression of Bromodomain and Extraterminal domain is associated with progression, metastasis and unfavorable outcomes: highlighting prognostic and therapeutic value of the BET protein family in gastric Cancer","volume":"23","author":"Fard","year":"2023","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"4","key":"10.1016\/j.bbamcr.2025.119986_bb0120","first-page":"177","article-title":"Bryostatin-1, Fenretinide and 1\u03b1,25 (OH)(2)D(3) induce growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6)","volume":"3","author":"Ardekani","year":"2011","journal-title":"Avicenna J. Med. Biotechnol."},{"issue":"5","key":"10.1016\/j.bbamcr.2025.119986_bb0125","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1165\/rcmb.2015-0022OC","article-title":"Effects of combining rapamycin and resveratrol on apoptosis and growth of TSC2-deficient xenograft tumors","volume":"53","author":"Alayev","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"52","key":"10.1016\/j.bbamcr.2025.119986_bb0130","doi-asserted-by":"crossref","first-page":"19988","DOI":"10.1074\/jbc.RA119.010821","article-title":"Inducible Exoc7\/Exo70 knockout reveals a critical role of the exocyst in insulin-regulated GLUT4 exocytosis","volume":"294","author":"Wang","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bbamcr.2025.119986_bb0135","article-title":"LAM-CAM - an in vivo model for rapid analysis of lymphangioleiomyomatosis tumor growth and inhibition","volume":"73","author":"Kundu","year":"2025","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.119986_bb0140","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a Cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbamcr.2025.119986_bb0145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13059-021-02540-7","article-title":"Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects","volume":"22","author":"Dempster","year":"2021","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.119986_bb0150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4161\/cc.27355","article-title":"Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells","volume":"13","author":"Alayev","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbamcr.2025.119986_bb0155","article-title":"Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism","volume":"2;26 (13)","author":"Wan","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbamcr.2025.119986_bb0160","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/MCB.00601-09","article-title":"mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling","volume":"30","author":"Julien","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.119986_bb0165","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jcb.24997","article-title":"The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells","volume":"116","author":"Alayev","year":"2015","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.119986_bb0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1513\/pats.200909-104JS","article-title":"Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy","volume":"7","author":"Yu","year":"2010","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.bbamcr.2025.119986_bb0175","doi-asserted-by":"crossref","first-page":"1015500","DOI":"10.3389\/fphys.2022.1015500","article-title":"Role of AMPK in autophagy","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.119986_bb0180","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/s41467-023-38401-z","article-title":"Redefining the role of AMPK in autophagy and the energy stress response","volume":"14","author":"Park","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbamcr.2025.119986_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105458","article-title":"Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complex","volume":"25","author":"McNamara","year":"2022","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.bbamcr.2025.119986_bb0190","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/s41598-019-39418-5","article-title":"Rapalog resistance is associated with mesenchymal-type changes in Tsc2-null cells","volume":"9","author":"Valianou","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2025.119986_bb0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-319-42118-6_3","article-title":"Metabolic reprogramming by the PI3K-Akt-mTOR pathway in Cancer","volume":"207","author":"Lien","year":"2016","journal-title":"Recent Results Cancer Res."},{"issue":"9","key":"10.1016\/j.bbamcr.2025.119986_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098391","article-title":"PI3K\/AKT\/mTOR dysregulation and reprogramming metabolic pathways in renal Cancer: crosstalk with the VHL\/HIF Axis","volume":"24","author":"Badoiu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbamcr.2025.119986_bb0205","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/onc.2010.468","article-title":"NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response","volume":"30","author":"Wang","year":"2011","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbamcr.2025.119986_bb0210","first-page":"6648","article-title":"Expression of NAMPT is associated with breast invasive ductal carcinoma development and prognosis","volume":"15","author":"Zhou","year":"2018","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.bbamcr.2025.119986_bb0215","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamadermatol.2016.0401","article-title":"Efficacy and safety of APO866 in patients with refractory or relapsed cutaneous T-cell lymphoma: a phase 2 clinical trial","volume":"152","author":"Goldinger","year":"2016","journal-title":"JAMA Dermatol."},{"issue":"6","key":"10.1016\/j.bbamcr.2025.119986_bb0220","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00280-009-1125-3","article-title":"Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data","volume":"65","author":"von Heideman","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbamcr.2025.119986_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28041897","article-title":"Anticancer activities of novel nicotinamide Phosphoribosyltransferase inhibitors in hematological malignancies","volume":"28","author":"Biniecka","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbamcr.2025.119986_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114504","article-title":"Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer","volume":"239","author":"Bai","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"45","key":"10.1016\/j.bbamcr.2025.119986_bb0235","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"Choo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.bbamcr.2025.119986_bb0240","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1080\/15548627.2024.2355074","article-title":"Unexpected roles for AMPK in the suppression of autophagy and the reactivation of MTORC1 signaling during prolonged amino acid deprivation","volume":"20","author":"Kazyken","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2025.119986_bb0245","doi-asserted-by":"crossref","first-page":"1469830","DOI":"10.3389\/fphar.2024.1469830","article-title":"The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbamcr.2025.119986_bb0250","first-page":"895","article-title":"Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status","volume":"122","author":"Usuki","year":"1998","journal-title":"Arch. Pathol. Lab Med."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.119986_bb0255","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jnci\/djx198","article-title":"Nicotinamide Phosphoribosyltransferase (NAMPT) as a therapeutic target in BRAF-mutated metastatic melanoma","volume":"110","author":"Audrito","year":"2017","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.bbamcr.2025.119986_bb0260","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41389-020-00264-0","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma","volume":"9","author":"Gibson","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbamcr.2025.119986_bb0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-med-050715-104245","article-title":"Lymphangioleiomyomatosis: a monogenic model of malignancy","volume":"68","author":"Krymskaya","year":"2017","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.119986_bb0270","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2018.05.024","article-title":"Selective cytotoxicity of the NAMPT inhibitor FK866 toward gastric Cancer cells with markers of the epithelial-mesenchymal transition, due to loss of NAPRT","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bbamcr.2025.119986_bb0275","first-page":"7231","article-title":"FK866 inhibits the epithelial-mesenchymal transition of hepatocarcinoma MHCC97-H cells","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:33:07Z","timestamp":1779539587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488925000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0167488925000916"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.119986","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of NAMPT as a therapeutic strategy to suppress tumor growth in lymphangioleiomyomatosis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.119986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119986"}}